Pharmacotherapy Of The Ion Transport Defect In Cystic Fibrosis-Reference-Cited by-同舟云学术

Pharmacotherapy Of The Ion Transport Defect In Cystic Fibrosis

Published:2001-11 Issue:11 Volume:28 Page:857-867
ISSN:0305-1870
Container-title:Clinical and Experimental Pharmacology and Physiology
language:en
Short-container-title:Clin Exp Pharmacol Physiol

Author:

Kunzelmann Karl,Mall Marcus

Publisher

Wiley

Subject

Physiology (medical),Pharmacology,Physiology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1046/j.1440-1681.2001.03541.x/fullpdf

Reference70 articles.

1. Identification of the Cystic Fibrosis Gene: Cloning and Characterization of Complementary DNA

2. CFTR Is a Conductance Regulator as well as a Chloride Channel

3. 4. KL. Kirk New paradigms of CFTR chloride channel regulation.Cell Mol. Life Sci.2000;57: 623-34.

4. 5. LR Choo-Kang, and PL. Zeitlin Type I, II, III, IV, and V cystic fibrosis transmembrane conductance regulator defects and opportunities for therapy.Curr. Opin. Pulm. Med.2000;6: 521-9.

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ion Transport: Potassium Channels;Encyclopedia of Respiratory Medicine;2022

2. Biodegradable microparticles designed to efficiently reach and act on cystic fibrosis mucus barrier;Materials Science and Engineering: C;2019-02

3. CFTR and Cystic Fibrosis;SpringerBriefs in Molecular Science;2017-10-04

4. Repairing the basic defect in cystic fibrosis - one approach is not enough;FEBS Journal;2015-10-18

5. The search for a common structural moiety among selected pharmacological correctors of the mutant CFTR chloride channel;Future Medicinal Chemistry;2014-11